Polyplus-transfection Commences Build of New Facility
Biotechnology company, Polyplus-transfection, has started construction of a new facility in France to meet growth in the cell and gene therapy market.
Biotechnology company, Polyplus-transfection, has announced in a Jan. 27, 2021 press release that it has started construction of a new facility in France to meet growth in the cell and gene therapy market.
The Vectura facility will be 4000 m2 and will house the company’s head office. Several immediate priorities will be fulfilled for the company upon the completion of the new facility, including doubling of the company’s headcount. Additionally, the new facility will provide additional manufacturing capacity for ex-vivo and in-vivo therapy products.
“The gene and cell therapy market continues to grow at a high rate, with more late-stage clinical trials moving towards commercialization, additionally supported by an increase in earlier stage therapies moving into the clinic. As a supplier of critical strategic materials for the sector, Polyplus-transfection will continue to invest to increase its capabilities and support its global customer base,” said Mario Philips, CEO, Polyplus-transfection, in the press release.
According to the company, the facility is expected to be operational in the third quarter of 2021.
Source: Polyplus-transfection
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
